Literature DB >> 19401454

Involvement of NADPH oxidase in oxidized LDL-induced upregulation of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells.

Ruozhi Zhao1, Xiuli Ma, Xueping Xie, Garry X Shen.   

Abstract

Plasminogen activator inhibitor-1 (PAI-1) is implicated in thrombogenesis, inflammation, and extracellular matrix remodeling. Previous studies indicated that oxidized low-density lipoprotein (LDL) stimulated the generation of PAI-1 in vascular endothelial cells (EC). The present study demonstrated that LDL oxidized by copper, iron, or 3-morpholinosydnonimine increased the expression of NADPH oxidase (NOX) 2, PAI-1, and heat shock factor-1 (HSF1) in human umbilical vein EC or coronary artery EC compared with LDL or vehicle. Diphenyleneiodonium, a NOX inhibitor, prevented the increases of the expression of HSF1 and PAI-1 in EC induced by oxidized LDLs. Small-interference RNA (siRNA) for p22(phox), an essential subunit of NOX, prevented oxidized LDL-induced expression of NOX2, HSF1, and PAI-1 in EC. HSF1 siRNA inhibited oxidized LDL-induced expression of PAI-1 and HSF1, but not NOX2, in EC. The binding of HSF1 to PAI-1 promoter and the activity of PAI-1 promoter in EC were enhanced by oxidized LDL. Butylated hydroxytulene, a potent antioxidant, inhibited oxidized LDL-induced release of hydrogen peroxide (H(2)O(2)) and the expression of NOX2, HSF1, and PAI-1 in EC. Treatment with H(2)O(2) increased the abundance of NOX2, HSF1, and PAI-1 in EC. The results of the present study indicate that oxidized LDL-induced expression of NOX may lead to the elevated release of reactive oxygen species, the activation of HSF1, and the enhancement of the transcription of PAI-1 gene in cultured vascular EC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401454     DOI: 10.1152/ajpendo.91023.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  15 in total

Review 1.  Interplay between the renin-angiotensin system, the canonical WNT/β-catenin pathway and PPARγ in hypertension.

Authors:  Alexandre Vallée; Bernard L Lévy; Jacques Blacher
Journal:  Curr Hypertens Rep       Date:  2018-06-09       Impact factor: 5.369

2.  Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles.

Authors:  Min Yu; Yiqun Mo; Rong Wan; Sufan Chien; Xing Zhang; Qunwei Zhang
Journal:  Toxicol Lett       Date:  2010-02-18       Impact factor: 4.372

3.  Native low density lipoprotein increases the production of both nitric oxide and reactive oxygen species in the human umbilical vein endothelial cells.

Authors:  Hyun Joong Yoon; Kee Oh Chay; Sung Yeul Yang
Journal:  Genes Genomics       Date:  2019-01-04       Impact factor: 1.839

4.  Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring.

Authors:  Eleanor Jarvie; Sylvie Hauguel-de-Mouzon; Scott M Nelson; Naveed Sattar; Patrick M Catalano; Dilys J Freeman
Journal:  Clin Sci (Lond)       Date:  2010-04-28       Impact factor: 6.124

5.  tPA Deficiency Underlies Neurovascular Coupling Dysfunction by Amyloid-β.

Authors:  Laibaik Park; Joan Zhou; Kenzo Koizumi; Gang Wang; Antoine Anfray; Sung Ji Ahn; James Seo; Ping Zhou; Lingzhi Zhao; Steven Paul; Josef Anrather; Costantino Iadecola
Journal:  J Neurosci       Date:  2020-09-14       Impact factor: 6.167

6.  Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients.

Authors:  Shosaku Nomura; Takehito Taniura; Akira Shouzu; Seitarou Omoto; Norihito Inami; Shinya Fujita; Takeshi Tamaki; Takashi Yokoi; Toshiki Shimizu; Tomoki Ito
Journal:  Int J Gen Med       Date:  2012-06-18

Review 7.  Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases.

Authors:  Yasuyoshi Kigawa; Takuro Miyazaki; Xiao-Feng Lei; Joo-Ri Kim-Kaneyama; Akira Miyazaki
Journal:  J Atheroscler Thromb       Date:  2016-07-29       Impact factor: 4.928

8.  Impact of exercise and metabolic disorders on heat shock proteins and vascular inflammation.

Authors:  Earl G Noble; Garry X Shen
Journal:  Autoimmune Dis       Date:  2012-12-17

9.  Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia.

Authors:  Minako Yamaoka-Tojo; Taiki Tojo; Rie Kosugi; Yuko Hatakeyama; Yuki Yoshida; Yoji Machida; Naoyoshi Aoyama; Takashi Masuda; Tohru Izumi
Journal:  Lipids Health Dis       Date:  2009-10-12       Impact factor: 3.876

10.  Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis.

Authors:  Yoshinori Okuda; Seitaro Omoto; Takehito Taniura; Akira Shouzu; Shosaku Nomura
Journal:  Int J Gen Med       Date:  2016-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.